These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1949499)

  • 1. The efficacy and safety of milrinone for treating heart failure in dogs.
    Kittleson MD
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):905-18. PubMed ID: 1949499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Milrinone. A clinical trial in 29 dogs with moderate to severe congestive heart failure.
    Keister DM; Kittleson MD; Bonagura JD; Pipers FS; Knauer KW
    J Vet Intern Med; 1990; 4(2):79-86. PubMed ID: 2187984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Young RA; Ward A
    Drugs; 1988 Aug; 36(2):158-92. PubMed ID: 3053125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic and clinical effects of milrinone in dogs with myocardial failure.
    Kittleson MD; Pipers FS; Knauer KW; Keister DM; Knowlen GG; Miner WS
    Am J Vet Res; 1985 Aug; 46(8):1659-64. PubMed ID: 4037492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with severe congestive heart failure treated with oral milrinone.
    Baim DS; Colucci WS; Monrad ES; Smith HS; Wright RF; Lanoue A; Gauthier DF; Ransil BJ; Grossman W; Braunwald E
    J Am Coll Cardiol; 1986 Mar; 7(3):661-70. PubMed ID: 3950244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of inotropic support of the failing heart.
    Knight DH
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):879-904. PubMed ID: 1949498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute hemodynamic effects of milrinone in dogs with severe idiopathic myocardial failure.
    Kittleson MD; Johnson LE; Pion PD
    J Vet Intern Med; 1987; 1(3):121-7. PubMed ID: 3506096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 4 classes of cardiovascular drugs on ventricular function in dogs with mitral regurgitation.
    Nakayama T; Nishijima Y; Miyamoto M; Hamlin RL
    J Vet Intern Med; 2007; 21(3):445-50. PubMed ID: 17552449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalment, survival, and prognostic factors in Doberman pinschers with end-stage cardiomyopathy.
    Calvert CA; Pickus CW; Jacobs GJ; Brown J
    J Vet Intern Med; 1997; 11(6):323-6. PubMed ID: 9470155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.
    Simonton CA; Chatterjee K; Cody RJ; Kubo SH; Leonard D; Daly P; Rutman H
    J Am Coll Cardiol; 1985 Aug; 6(2):453-9. PubMed ID: 4019930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR
    Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
    Remme WJ; van Hoogenhuyze DC; Kruijssen HA; Pieper PG; Bruggeling WA
    Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial and vascular actions of milrinone.
    Colucci WS
    Eur Heart J; 1989 Aug; 10 Suppl C():32-8. PubMed ID: 2680495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term use of intravenous milrinone for heart failure.
    Konstam MA; Cody RJ
    Am J Cardiol; 1995 Apr; 75(12):822-6. PubMed ID: 7717288
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of milrinone in the management of congestive heart failure.
    Hilleman DE; Forbes WP
    DICP; 1989 May; 23(5):357-62. PubMed ID: 2658377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferences of veterinarians for drugs to treat heart disease in dogs and cats.
    Watson AD; Church DB
    Aust Vet J; 1995 Nov; 72(11):401-3. PubMed ID: 8929183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milrinone for long-term therapy of severe heart failure: clinical experience with special reference to maximal exercise tolerance.
    LeJemtel TH; Gumbardo D; Chadwick B; Rutman HI; Sonnenblick EH
    Circulation; 1986 Mar; 73(3 Pt 2):III213-8. PubMed ID: 3510777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The population pharmacokinetics of digoxin in dogs with heart disease.
    Whittem T; Hogan D; Sisson D; Cooper T
    J Vet Pharmacol Ther; 2000 Aug; 23(4):261-3. PubMed ID: 11126326
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparing the effects of milrinone and olprinone in patients with congestive heart failure.
    Dobashi S; Watanabe I; Nakanishi R; Hisatake S; Kiuchi S; Kabuki T; Oka T; Fujii T; Ikeda T
    Heart Vessels; 2020 Jun; 35(6):776-785. PubMed ID: 31865433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.